Point: Why statins have failed to reduce mortality in just about anybody by Vos, Eddie, MEng, Rose, Colin P., MD, PhD, Biron, Pierre, MD

Get full text

Rebuttal: Why statins have failed to reduce mortality in just about anybody by Vos, Eddie, MEng, Rose, Colin P., MD, PhD, Biron, Pierre, MD

Get full text

Regarding “Does simvastatin save lives; If so, when and in whom?” by Vos, Eddie, M. Eng, Mascitelli, Luca, MD, Rose, Colin P., MD

Get full text

Blood pressure drugs have no mortality benefit in diabetic patients by Vos, Eddie, MEng, Rose, Colin P., MD PhD, Biron, Pierre, MD

Get full text

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase... by Récher, Christian, Prof, Coiffier, Bertrand, Prof, Haioun, Corinne, Prof, Molina, Thierry Jo, Prof, Fermé, Christophe, MD, Casasnovas, Olivier, MD, Thiéblemont, Catherine, Prof, Bosly, André, Prof, Laurent, Guy, Prof, Morschhauser, Franck, MD, Ghesquières, Hervé, MD, Jardin, Fabrice, Prof, Bologna, Serge, MD, Fruchart, Christophe, MD, Corront, Bernadette, MD, Gabarre, Jean, MD, Bonnet, Christophe, MD, Janvier, Maud, MD, Canioni, Danielle, Prof, Jais, Jean-Philippe, MD, Salles, Gilles, Prof, Tilly, Hervé, Dr, Prof

Get full text

Higher Stroke Risk with Lower Blood Pressure in Hemodynamic Vertebrobasilar Disease: Analysis from the VERiTAS Study by Amin-Hanjani, Sepideh, MD, Turan, Tanya N., MD, MSCR, Du, Xinjian, MD, MPH, Pandey, Dilip K., MD, PhD, Rose-Finnell, Linda, MPA, Richardson, DeJuran, PhD, Elkind, Mitchell S.V., MD, MS, Zipfel, Gregory J., MD, Liebeskind, David S., MD, Silver, Frank L., MD, Kasner, Scott E., MD, Gorelick, Philip B., MD, MPH, Charbel, Fady T., MD, Derdeyn, Colin P., MD

Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass su... by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the Tra... by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

Get full text